NASDAQ · Drug Manufacturers - Specialty & Generic

OGI (OGI) Stock

$0.94 +0.50% NASDAQ: OGI Healthcare

Valuation

MetricValue
Price$0.94
Market Cap$132.24M
P/E Ratio47.50
P/B Ratio0.52
P/S Ratio0.72
EPS (TTM)$0.11
52-Week High$2.24
52-Week Low$0.86
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.92%
ROA-1.67%
ROCE-18.05%
Gross Margin-3.07%
Operating Margin-38.62%
Net Margin-9.19%
Debt/Equity0.02
Current Ratio2.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$79.0M$146.0M$149.0M$160.0M$186.0M
Operating Profit$-92.0M$-43.0M$-243.0M$-36.0M$-63.0M
Net Profit$-131.0M$-14.0M$-229.0M$-45.0M$-18.0M
EPS$-2.04$-0.18$-2.82$-0.48$-0.14
Op Margin-116.0%-29.6%-162.7%-22.3%-34.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$554.0M$577.0M$298.0M$408.0M$562.0M
Total Liabilities$74.0M$69.0M$27.0M$102.0M$213.0M
Cash$55.0M$69.0M$34.0M$107.0M$28.0M
Borrowings$6.0M$3.0M$4.0M$4.0M$9.0M

Latest News

Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share Business Wire · Jul 20, 2026 Organigram Global Inc (OGI) Raises 2026 Guidance on Sanity Acquisition Insider Monkey · May 31, 2026 Weekly Roundup on the Cannabis Sector & Psychedelic Sector Market Exclusive · May 18, 2026 OrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call Transcript Benzinga · May 13, 2026 Transcript: OrganiGram Holdings Q2 2026 Earnings Conference Call Benzinga · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-36.0M$-36.0M$4.0M$-4.0M
Investing Cash Flow$-127.0M$-5.0M$7.0M$-44.0M$-72.0M
Financing Cash Flow$6.0M$6.0M$-1.0M$0$-1.0M
Net Cash Flow$31.0M$13.0M$-69.0M$73.0M$-38.0M
Free Cash Flow$-41.0M$-85.0M$-63.0M$-1.0M$-17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio78.02
EV / EBITDA67.57
FCF Yield-10.17%
Quick Ratio1.30
Interest Coverage—
Return 1Y-39.86%
Return 3Y-42.95%
Return 5Y-91.67%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACB $2.72 -0.73% 115.33 $168.48M 0.00%
DERM $6.31 -0.94% -13.53 $173.66M 0.00%
ELMD $39.48 -0.95% 32.25 $326.90M 0.00%
HSDT $1.69 +0.60% -1.25 $98.67M 0.00%
INFU $9.92 +5.98% 32.90 $200.20M 0.00%

About OGI

OGI is led by CEO James H. Yamanaka, employs 1,093 people, headquartered in CA, publicly traded since 2019.

OGI stock trades at $0.94 with a market capitalization of $132.24M. The stock is valued at a price-to-earnings (P/E) ratio of 47.50, price-to-book of 0.52, price-to-sales of 0.72. Over the past 52 weeks the stock has ranged between $0.86 and $2.24, and currently trades 58.0% below its 52-week high.

On profitability, OGI generates a return on equity (ROE) of -5.92%, return on capital employed of -18.05%, an operating margin of -38.62%, a net profit margin of -9.19%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides